Scarica l'app Stockscreener
131.14
0.41%
0.54
Dopo l'orario di chiusura:
133.00
1.86
+1.42%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché A Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$130.60
Aprire:
$131.82
Volume 24 ore:
2.44M
Relative Volume:
1.09
Capitalizzazione di mercato:
$37.04B
Reddito:
$7.23B
Utile/perdita netta:
$1.41B
Rapporto P/E:
26.34
EPS:
4.979
Flusso di cassa netto:
$1.09B
1 W Prestazione:
-1.27%
1M Prestazione:
-3.17%
6M Prestazione:
-11.28%
1 anno Prestazione:
+9.97%
Intervallo 1D:
$129.99
$132.79
Intervallo di 1 settimana:
$128.05
$135.71
Portata 52W:
$108.35
$160.27
Agilent Technologies Inc Stock (A) Company Profile
Nome
Agilent Technologies Inc
Settore
Industria
Telefono
(408) 345-8886
Indirizzo
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, IDXX, NTRA
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
A
Agilent Technologies Inc
|
131.14 | 36.89B | 7.23B | 1.41B | 1.09B | 4.979 |
TMO
Thermo Fisher Scientific Inc
|
516.62 | 192.35B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
194.19 | 137.04B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
570.25 | 44.57B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
281.27 | 40.64B | 2.50B | -226.32M | 71.51M | -1.6412 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-20 | Iniziato | HSBC Securities | Buy |
| 2026-01-05 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-12-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-02 | Iniziato | Morgan Stanley | Overweight |
| 2025-10-08 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-10-08 | Aggiornamento | UBS | Neutral → Buy |
| 2025-02-10 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-06-27 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-04-05 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-11-17 | Downgrade | UBS | Buy → Neutral |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-31 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-05-24 | Reiterato | Barclays | Equal Weight |
| 2023-05-24 | Reiterato | BofA Securities | Buy |
| 2023-05-24 | Reiterato | Citigroup | Neutral |
| 2023-05-24 | Reiterato | Credit Suisse | Outperform |
| 2023-05-24 | Reiterato | Evercore ISI | Outperform |
| 2023-05-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-24 | Reiterato | Robert W. Baird | Outperform |
| 2023-05-24 | Reiterato | SVB Securities | Outperform |
| 2023-05-24 | Reiterato | Stifel | Hold |
| 2023-05-24 | Reiterato | TD Cowen | Outperform |
| 2023-05-24 | Reiterato | Wells Fargo | Overweight |
| 2023-05-11 | Iniziato | Barclays | Equal Weight |
| 2023-01-10 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-07-20 | Iniziato | UBS | Buy |
| 2022-07-08 | Downgrade | Citigroup | Buy → Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-02-23 | Reiterato | BofA Securities | Buy |
| 2022-02-23 | Reiterato | Citigroup | Buy |
| 2022-02-23 | Reiterato | Cowen | Outperform |
| 2022-02-23 | Reiterato | Evercore ISI | Outperform |
| 2022-02-23 | Reiterato | Stifel | Hold |
| 2022-02-23 | Reiterato | Wells Fargo | Overweight |
| 2021-11-23 | Reiterato | BofA Securities | Buy |
| 2021-11-23 | Reiterato | Cowen | Outperform |
| 2021-11-23 | Reiterato | Stifel | Hold |
| 2021-03-18 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-02-17 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-25 | Aggiornamento | UBS | Neutral → Buy |
| 2020-11-17 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-09-30 | Iniziato | Atlantic Equities | Neutral |
| 2020-08-19 | Reiterato | BofA Securities | Neutral |
| 2020-08-19 | Reiterato | Citigroup | Neutral |
| 2020-08-19 | Reiterato | Jefferies | Buy |
| 2020-08-19 | Reiterato | Robert W. Baird | Outperform |
| 2020-08-19 | Reiterato | SVB Leerink | Outperform |
| 2020-08-19 | Reiterato | Stifel | Hold |
| 2020-08-19 | Reiterato | Wells Fargo | Overweight |
| 2020-02-24 | Downgrade | Needham | Buy → Hold |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Neutral |
| 2019-11-26 | Reiterato | Needham | Buy |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-10-18 | Downgrade | UBS | Buy → Neutral |
| 2019-07-16 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-07-15 | Downgrade | Barclays | Overweight → Equal Weight |
Mostra tutto
Agilent Technologies Inc Borsa (A) Ultime notizie
Agilent 6560 Ion Mobility LC/Q-TOF from Agilentniche lab workhorse gains quiet momentum - AD HOC NEWS
Agilent (A) Stock Looks Below Fair Value On Cash Flow - Yahoo Finance Singapore
Agilent Technologies focuses on lab instrumentation and diagnostics - AD HOC NEWS
Evercore Maintains Agilent Technologies(A.US) With Buy Rating, Raises Target Price to $148 - Moomoo
Agilent rises on Q2 beats; adjusts fiscal 2026 guidance - MSN
Evercore ISI Adjusts Agilent Technologies PT to $148 From $144 - marketscreener.com
Agilent Technologies focuses on analytical tools for growth - AD HOC NEWS
Agilent Technologies, Inc. (A) Stock Analysis: Strong Buy Ratings Signal a Potential 22.68% Upside - DirectorsTalk Interviews
Agilent Technologies stock follows a data-light setup. Investors watch the next filing cycle. - AD HOC NEWS
Why Agilent Stock Is Slipping Premarket Today - Stocktwits
Agilent Technologies focuses on lab instrumentation and diagnostics as investors weigh the long-term - AD HOC NEWS
Agilent (A) Launches AI Cell Imaging Software For Biopharma Research - Sahm
Agilent Technologies steadies on business focus. - AD HOC NEWS
AAgilent Technologies Inc Latest SEC Filings - Finviz
Agilent Technologies Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Agilent (A) Unveils AI-Enhanced Software for Improved Cell Imagi - GuruFocus
Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight - 巴士的報
Agilent 1260 Infinity II LC System from Agilent Technologies Inc.midrange workhorse for US analyt - AD HOC NEWS
Agilent TechnologiesIgnite raises the full-year outlook - AD HOC NEWS
Agilent Bravo NGS Auto Prep System from Agilent Technologies Inc.Automating genomic workflows for - AD HOC NEWS
Jefferies Initiates Agilent Technologies(A.US) With Buy Rating, Announces Target Price $550 - Moomoo
Agilent Technologies consensus picture, shares trade steadily on the NYSE - AD HOC NEWS
Form 4 Agilent Technologies For: 29 June By Investing.com - Investing.com South Africa
Agilent Technologies Inc. stock underperforms Monday when compared to competitors - MarketWatch
Agilent (NYSE: A) SVP surrenders 30 shares to cover RSU tax liability - Stock Titan
InfinityLab LC Series 1260 Infinity II from Agilent Technologies Inc.flexible mid-range workhorse - AD HOC NEWS
Accurate mAb Sizing Using The NIST mAb As A Ladder For The Agilent ProteoAnalyzer System - Bioprocess Online
Agilent Technologies sets $600 million note deal, shares supported by debt market access - AD HOC NEWS
Agilent Technologies, Inc. (A) Stock Analysis: Unpacking a 17.88% Potential Upside for Investors - DirectorsTalk Interviews
Agilent Inlet Liners from Agilent Technologies Inc.small glass parts, big impact on GC precision - AD HOC NEWS
Oxidative Stress Assay Market Size to Reach USD 3.25 Billion by 2035 | SNS Insider - GlobeNewswire Inc.
The 8890 GC System from Agilent Technologies Inc.a classic gas chromatograph for modern labs - AD HOC NEWS
InfinityLab LC Series from Agilent Technologies Inc.modular HPLC workhorse for busy labs - Ad-hoc-news.de
Agilent Completes Acquisition Of Biocare Medical - Pulse 2.0
Agilent lifts outlook after Q2, shares hold above consensus - Ad-hoc-news.de
Enterprise value to EBIT forward of Agilent Technologies, Inc. – BOATS:A - TradingView
A6433334 Latest News and Headlines - TradingView
Price to earnings forward of Agilent Technologies, Inc. – NYSE:A - TradingView
Agilent (A) Receives Outperform Rating with $155 Price Target - GuruFocus
Agilent Completes $600 Million Senior Notes Offering - The Globe and Mail
There's A Lot To Like About Agilent Technologies' (NYSE:A) Upcoming US$0.255 Dividend - 富途牛牛
Bernstein SocGen resumes Agilent stock coverage with outperform rating - Investing.com UK
Agilent Technologies, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 1/2 Sh - TradingView
Bernstein SocGen resumes Agilent stock coverage with outperform rating By Investing.com - Investing.com South Africa
Why Is Agilent (A) Up 0.1% Since Last Earnings Report? - Yahoo Finance
Is Agilent Technologies (NYSE:A) Still A Reliable Dividend Story? - Kalkine Media
Agilent finalizes Biocare Medical takeover - MedTech Dive
Agilent 8890 GC System from Agilent Technologies Inc.flexible chromatograph for demanding labs - Ad-hoc-news.de
Bernstein Upgrades Agilent Technologies(A.US) to Buy Rating, Raises Target Price to $155 - Moomoo
Agilent Technologies, Inc. (NYSE:A) Passed Our Checks, And It's About To Pay A US$0.255 Dividend - simplywall.st
Agilent Technologies completes Biocare deal, shares react to healthcare expansion - Ad-hoc-news.de
Agilent Technologies Inc Azioni (A) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.05%
1.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):